Helpline 07939 046 030

Artificial Intelligence & Disability Recruitment

13 August 2020

The Institute for Ethical Artificial Intelligence is launching its new white paper, "Recruitment AI has a Disability Problem: questions employers should be asking to promote fairness."

They invited a roundtable of experts to discuss how AI and advanced analytics technologies impact the life chances of people with disability and discuss strategies for ethically procuring and deploying technologies for recruitment. In doing so, they further the point that making systems fairer for disabled users, ensures systems are fairer for all.  

The Institute for Ethical Artificial Intelligence is there to help organisations working in the professional services to understand and plan for the risks and opportunities that AI and data analysis technologies can bring to their organisation, their stakeholders and society at large. Working with both the users and the providers of AI technology, as well as developing bespoke AI solutions, they research and advise on the ethical impact of AI technology on organisations and individuals. In order to achieve this, bringing together a diverse group of world-leading experts who together blend knowledge and skills from technology, business, social science and the life sciences. With the aim to deliver expertise and independent guidance in areas that include AI and machine learning, disability, psychology, business development, equality, and diversity, coaching and mentoring, digital health, and wellbeing.  Specific issues arose on understanding how AI technology might discriminate against those that have a visible disability in face recognition software. We at Nerve Tumours UK and as part of Face Equality international support their work in deploying fair processes to everyone using AI technology in the employment process and want to make sure that this is in place as part of any new technology role out. If you or anyone might be affected in the employment process by Artificial Intelligence have a read or let us know if you have any questions. 

The Panel included: 

Nigel Crook - Professor of Artificial Intelligence and Robotics at Oxford Brookes University and Founder of the Institute for Ethical Artificial Intelligence

Academic lecturer and researcher with nearly 30 years of experience in the field of AI. Prof Crook is interested in the areas of explainability, autonomous moral machines, and ethical AI.

Julian Burnett - VP, Global Markets at IBM

A senior business & technology leader, Top 40 CIO/CTO specialising in digital transformation and growth of retail & consumer industry businesses.

Susan Scott-Parker, OBE HonD - Founder of Business Disability International and Business Disability Forum.

Internationally recognised as a thought leader on how to mobilise business behind the economic and social inclusion of people with disabilities worldwide.

James Partridge OBE, DSc (Hon) - Founder of Face Equality International

An influential advocate for 'face equality' and challenging disfigurement prejudice and discrimination. He writes and presents widely on disfigurement, disability, inclusion and social entrepreneurship in the UK and internationally, including for his latest book, Face IT: Facial Disfigurement and My Fight for Face Equality (Pebble Press, 2020).

The event will be hosted by:

Paul Jackson MSc, PhD - Principal Consultant, Institute for Ethical AI, Oxford Brookes University School of Business

Academic researcher, lecturer and management adviser, with expertise in digital innovation and systems analysis.

Selin Nugent MA, PhD - Assistant Director of the Institute for Ethical Artificial Intelligence, Oxford Brookes University

Computational anthropologist whose research focuses on the social and behavioural impacts of technology, particularly in the areas of employment, organisational behaviour, and inequality.

The Institute for Ethical AI & Machine Learning

The Institute for Ethical AI & Machine Learning is a UK-based research centre that carries out highly-technical research into processes and frameworks that support the responsible development, deployment and operation of machine learning systems. https://ethical.institute/

Filter News

Filter by Date
Category
Reset

Rare Disease Day 2024

Read our update on the events and meetings NTUK attended to help raise awareness of NF

Read More

Johnathan’s story

Johnathon's family are spreading awareness of the importance of attending health checks and advocating for vulnerable people

Read More

Jen’s NF1 story

Jen praises the great support received since her NF1 diagnosis, allowing her to thrive & achieve a 1st class degree.

Read More

Charlotte & Evie’s story

'Sticker Queen' Evie is 4 years old and was diagnosed with NF1 after tests for a 'lazy eye'.

Read More

Luke’s Story

Luke had NF1 since childhood. Now an adult, surgery last year has enabled him to play football and do whatever he wants

Read More

Charlotte’s Story

When Charlotte was 6, she was diagnosed with NF1, along with her brother & dad. Now she is on a mission to raise awareness

Read More

Eden P Study

Currently pregnant? Please consider taking part in the Eden P study

Read More

Eden P for healthcare professionals

Healthcare professionals, who provide support to expectant parents with NF1 are invited to take part in the Eden P study

Read More

Nicole’s story

Nicole has NF2, she describes the preparations and the absolute joyful experience of the birth of her son Lewis

Read More

Masterclasses in NF: Constitutional Mismatch Repair Deficiency Syndrome as Differential Diagnosis to NF1/Legius Syndrome - Prof. Dr. Katharina Wimmer

Constitutional Mismatch Repair Deficiency Syndrome as Differential Diagnosis to NF1/Legius Syndrome

Prof. Dr. Katharina Wimmer, Medical University of Innsbruck

Masterclasses in NF: Rare NF1-Associated Tumors in Adults - Eric Legius & Prof. Ellen Denayer

Masterclasses in NF: Rare NF1-Associated Tumors in Adults

Eric Legius, MD, PhD, University Hospital Leuven

Prof. Ellen Denayer, University Hospital Leuven

Masterclasses in NF: Optimising Hearing Outcomes in NF2-Related Schwannomatosis - Simon Freeman

Masterclasses in NF: Optimising Hearing Outcomes in NF2-Related Schwannomatosis

Simon Freeman, MPhil FRCS, Manchester Royal Infirmary and Salford Royal Hospital

Masterclasses in NF: NF1 Dermatological Manifestations - Pierre Wolkenstein, Laura Fertitta & Sirkku Peltonen

Masterclasses in NF: NF1 Dermatological Manifestations

Pierre Wolkenstein, MD, PhD, Hopital Henri-Mondor, Paris, France

Laura Fertitta, MD, Hôpital Universitaire Henri Mondor

Sirkku Peltonen, MD, PhD, University of Gothenberg, Sweden

Masterclasses in NF: Breast Cancer in NF1 - Gareth Evans

Masterclasses in NF: Breast Cancer in NF1

Gareth Evans, MD, University of Manchester, UK

Masterclasses in NF: Pain in Non-NF2-Related Schwannomatosis - David Pang

Masterclasses in NF: Pain in Non-NF2-Related Schwannomatosis

David Pang, MD, ChB. Guys and St Thomas' Hospital NHS Trust, London

Masterclasses in NF: Distinguishing Non-NF2-Related from NF2-Related Schwannomatosis - Clinical and Genetic Approaches - Said Farschtschi

Masterclasses in NF: Distinguishing Non-NF2-Related from NF2-Related Schwannomatosis - Clinical and Genetic Approaches

Said Farschtschi, MD, University Medical Center, Hamburg-Eppendorf, Germany

Masterclasses in NF: NF1 Pre-Implantation Genetic Diagnosis - Eric Legius & Prof. Ellen Denayer

Masterclasses in NF: NF1 Pre-Implantation Genetic Diagnosis

Eric Legius, MD, PHD, University Hospital of Leuven, Belgium

Prof. Ellen Denayer, University Hospital of Leuven, Belgium

NF2 Working Together: from a tentative diagnosis and beyond

Understanding the impact that a tentative diagnosis has on a parent. Information and access to the existing NTUK and Specialist Nerve Tumours medical and non medical care network.

NF1 Working Together Part 2: from a tentative diagnosis and beyond

Understanding the impact that a tentative diagnosis has on a parent. Information and access to the existing NTUK and Specialist Nerve Tumours medical and non medical care network.

NF1 Working Together Part 1: from a tentative diagnosis and beyond

Understanding  the impact that a tentative diagnosis has on a parent. Information and access to the existing NTUK and Specialist Nerve Tumours medical and non medical care network.

Masterclasses in NF: Surgery in NF2 - Michel Kalamarides & Andrew King

Masterclasses in NF: Surgery in NF2

Michel Kalamarides, MD, PhD, Hôpital Pitié-Salpêtrière, Paris, France

Prof Andrew King, MBBS FRCS FRCS(SN), Salford Royal Hospital, Manchester, United Kingdom. Member of the MAB of Nerve Tumours UK

Masterclasses in NF: Cognition and Behaviour in NF1: Phenotype and Treatment Approaches - Shruti Garg, Andre Rietman

Masterclasses in NF: Cognition and Behaviour in NF1: Phenotype and Treatment Approaches

Dr Shruti Garg, MBBS, MRCPsych, MMedSci, PhD, Royal Manchester Children’s Hospital, United Kingdom. Member of the MAB of Nerve Tumours UK

Andre Rietman, PhD, Erasmus University Medical Center, Rotterdam, Netherlands

Masterclasses in NF: Emotional Challenges in NF1, NF2 and Schwannomatosis - Susie Henley, Thomas Pletschko & Verena Rosenmayr

Masterclasses in NF: Emotional Challenges in NF1, NF2 and Schwannomatosis

Susie Henley, DClinPsy, PhD, Guy’s and St Thomas’ NHS Foundation Trust, London UK

Thomas Pletschko, PhD, Medical University of Vienna, Austria

Verena Rosenmayr, Clinical Psychologist, Medical University of Vienna, Austria

Masterclasses in NF: NF1 Pediatric Management - Rianne Oostenbrink

Masterclasses in NF: NF1 Pediatric Management

Rianne Oostenbrink, MD, PhD, Erasmus University Medical Center, Rotterdam, Netherlands

Masterclasses in NF: Associated Glioma in Children - the Optic Pathway and Beyond - Amedeo Azizi

Masterclasses in NF: Associated Glioma in Children - the Optic Pathway and Beyond

Amedeo Azizi, MD, PhD, Head of the Paediatric Neurofibromatosis Program and Paediatric Neuro-Oncology Program, Medical University of Vienna, Austria

Masterclasses in NF: NF1 Orthopedic Manifestations - Eric Legius and Christophe Glorion

Masterclasses in NF: NF1 Orthopedic Manifestations

Eric Legius, MD, PhD. Head of Clinical Genetics Department of the University Hospital Leuven, Belgium

Christophe Glorion, MD, PhD, Department of Paediatric Orthopedic and Traumatologic Surgery, Hopital Necker-Enfants Malades, Paris, France. 

Masterclasses in NF: NF1 Malignant Peripheral Nerve Sheath Tumours - Rosalie Ferner and Viktor-Felix Mautner

Masterclasses in NF: NF1 Malignant Peripheral Nerve Sheath Tumours

Prof Rosalie Ferner, Consultant Neurologist and Lead Clinician for Neurofibromatosis, Guy's and St. Thomas' NHS Foundation Trust, London. Member of the MAB of Nerve Tumours UK and Trustee of Nerve Tumours UK

Viktor-Felix Mautner, MD, PhD. University Medical Centre in Hamburg-Eppendorf, Germany. Head of NF Outpatient Department

Masterclasses in NF - Neurofibromatosis Type 1: Cutaneous Neurofibromas - Pierre Wolkenstein and Sirkku Peltonen

Masterclasses in NF - Neurofibromatosis Type 1: Cutaneous Neurofibromas

Pierre Wolkenstein, MD, PhD. Hopital Henri-Mondor, Paris, France. Head of the Department of Dermatology

Sirkku Peltonen MD, PhD. University of Gothenberg, Sweden. Professor of Dermatology

INFER (International NF Educational Resources) is a series of online educational lectures for medical professionals by leading neurofibromatosis experts. The Masterclasses take place online approximately once a month, each on a different topic, and include real-time interaction between the expert presenter and the participants. The presentations are conducted in English, with real-time audio interpretation available in 6 additional languages: French, German, Italian, Portuguese, Russian, and Spanish. A recording of each INFER masterclass is then be made available online in each language for those who could not attend an event. INFER is an initiative of Children’s Tumor Foundation Europe, supported by an educational grant from AstraZeneca. https://ctfeurope.org/research/masterclasses-in-nf

BPNA Keynote Lecture - Prof Rosalie Ferner - Neurofibromatosis 1 in the 21st Century

‘Neurofibromatosis 1 in the 21st Century’

Keynote Lecture at the 48th British Paediatric Neurology Association Annual Scientific Meeting on 21st January 2022

Prof Rosalie Ferner, Consultant Neurologist and Lead Clinician for Neurofibromatosis, Guy's and St. Thomas' NHS Foundation Trust, London. Member of the MAB of Nerve Tumours UK and Trustee of Nerve Tumours UK